Order Amending Schedule I to the Controlled Drugs and Substances Act (Tramadol): SOR/2021-44

Canada Gazette, Part II, Volume 155, Number 7

Registration

SOR/2021-44 March 18, 2021

CONTROLLED DRUGS AND SUBSTANCES ACT

P.C. 2021-157 March 17, 2021

His Excellency the Administrator of the Government of Canada in Council, on the recommendation of the Minister of Health, pursuant to section 60 ^{footnote a} of the Controlled Drugs and Substances Act ^{footnote b}, considering that it is necessary in the public interest, makes the annexed Order Amending Schedule I to the Controlled Drugs and Substances Act (Tramadol).

Order Amending Schedule I to the Controlled Drugs and Substances Act (Tramadol)

Amendment

1 Schedule I to the Controlled Drugs and Substances Act ^{footnote b} is amended by adding the following after item 26:

27 Tramadol (2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol), its salts, isomers and salts of isomers and the following derivatives of tramadol and the salts, isomers and salts of isomers of those derivatives:

• (1) O-desmethyltramadol (3-[2-[(dimethylamino)methyl]-1hydroxycyclohexyl]-phenol)
• (2) N,O-didesmethyltramadol (3-[1-hydroxy-2[(methylamino)methyl]cyclohexyl]phenol)

Coming into Force

2 This Order comes into force on the first anniversary of the day on which it is published in the Canada Gazette, Part II.

N.B. The Regulatory Impact Analysis Statement for these Regulations appears following SOR/2021-43, Regulations Amending the Narcotic Control Regulations (Tramadol).